This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Ingo Bernard Runnebaum (born 21. September 1960 in Cologne) is a german specialist, university professor and director of the Clinic Obstetrics and Gynecology in Jena. His special focus lies on oncology and gene therapy.
Biography
editFrom 1982 until 1988 Runnebaum studied medicine in Mainz, Berlin and Munich. In 1989 he started to work at the Salk Institute for Biological Studies in San Diego as a PostDoc. In a working group of Renato Dulbecco, which was lead by Saraswati Sukuma he researched about p53 until 1992.[1] In 1990 he obtained a doctorate of the Ludwig Maximilian University of Munich and in 1997 he was certified as specialist by the Medical Association Baden-Württemberg. With his qualification as a professor at the University of Ulm with authorisation to teach gynecology and obstetrics he is following in his father's footsteps. Between 1997 and 2005 Runnebaum first worked as senior physician at the University Women's Hospitals in Freiburg and Ulm and then as deputy director with special emphasis on gynaecological and oncological operations. In addition he gained a Master's degree in business administration in 2005. In the same year he became university professor at the Friedrich-Schiller-University Jena as well as executive director of the University Women's Hospitals. Furthermore he became director of the department General Gynaecology and head of the Interdisciplinary Breast Center Jena where he still works today.[2] Beside his clinical and operations activities, Runnebaum is known for about 100 scientific contributions, over 100 specialist lectures in Germany and Europe, his teaching activity and trainings for physicians as well as for numerous television appearances on Sat.1, RTL Television and Mitteldeutscher Rundfunk.
Specialization
editRunnebaum is expert on breast cancer/gynecological tumors. He has specialized on oncoplastic operations which enable breast conservation, removal of sentinel lymph nodes and removal of pelvic tumours through laparoscopy (laparoscopic surgeries also during Uterus myomatosus greater than 1000g, deeply infiltrating endometriosis, radical hysterectomy conserving nerves, lymphadenectomies and complex operations of genital cancer]]. Beside gynecology, oncology and endocrinology the State Chamber of Medicine has additionally recognized the following expert areas: reproductive medicine, perinatal care and special stetrics as well as gene therapy according to his scientific activity. The focus of his institute research, data gathering and supported projects lies in the field of ovarian, cervix and mammary tumors.
Scientific contribution
editRunnebaum strengthened the evidence of the performance and therapeutical usage of the p53-gene as a tumor suppressor gene as well as the rolle of integrins within the adenoviral cell entry of ovarian cancer. After his contribution to the foundation of the University Tumor Centre Jena[3] in 2008, Runnebaum founded the Endometriosis Center in Jena, the University Pelvic Floor Center, the Pelvic Floor Network Thüringen and in 2010 the Oncology Center in Jena.
Awards
editIn 1994 Runnebaum received the Walter-Hohlweg-Price for his investigations on p53 as tumour suppressor genes and cell cycle regulator.
Memberships in scientific organizations
editRunnebaum is member of numerous german scientific organizations. The international ones include the following:
- American Association for Cancer Research (AACR)
- American Society of Clinical Oncology (ASCO)
- European Society for Gynaecological Endoscopy (ESGE)
- European Society for Gynaecological Oncologists (ESGO)
- European Group for Breast Cancer Screening
Publications
editReferences
editExternal links
edit